An MS relapse and the end of a relationship leave columnist Ahna Crum feeling unsafe and unsure about the world around her.

An X chromosome gene appears to drive inflammation in the brain, and may explain why women are more likely to develop MS, per ...

Liberate Bio’s CAR-M cell therapy almost completely depleted B-cells in a nonhuman primate study, the company said.

Trageting abnormal brain cells linked to chronic inflammation may be key to treating people with progressive forms of MS, a ...

Jana Hlavacova, a Czech government employee who lives with MS, is helping shape policies in healthcare and the design of ...

Jill Blackburn, a pediatric MS mom, founded the Pediatric Multiple Sclerosis Alliance to help other families of kids with the ...

Tr1X has won an FDA green light for a clinical trial testing TRX319, a cell therapy designed to restore immune balance, for ...

Compassion means listening to your body without guilt and sometimes avoiding just "pushing through," writes columnist.

EG110A received FDA fast track designation to treat neurogenic detrusor overactivity, a bladder issue common in MS.

People with MS are more than twice as likely to experience headaches, including migraines, than their healthy counterparts, per a study.

According to columnist Ben Hofmeister, MS forces him to become a jack-of-all-trades in managing symptoms and daily tasks. There are benefits.

Kernal Biologics has been awarded up to $48 million in funding to accelerate the development of KR-402, a next-generation CAR T-cell therapy for multiple sclerosis (MS) and certain blood cancers.